NACB News and Views
Page Access:

News and Views Banner 

 

NACB CONGRATULATES 2009 DISTINGUISHED ABSTRACT WINNERS

 

The National Academy of Clinical Biochemistry is pleased to announce the winners of the 2009 Distinguished Abstract Awards.  825 abstracts accepted for the AACC Annual Meeting were submitted to a second scientific review by a group of NACB Fellows and 22 were identified as representing outstanding research worthy of special recognition. 

Winning abstracts will be marked with the NACB blue ribbon and may be viewed during the Annual Meeting poster session on the day indicated below. 

Tuesday, July 21, 10:00 am

A-3 Tania S. Frode
Down-regulation of Antioxidant Status and Lipid Peroxidation in the Inflamed Pleural Cavity of Mice Treated with Mycophaenolate Mofetil

A-31 Raffick A.R. Bowen
Improvements in Turnaround Time (TAT) after Computerized Autoverification in a Rapid Response Clinical Chemistry Laboratory

Tuesday, July 21, 2:00 pm

B-77 Ioannis Papassotiriou
Soluble Endoglin and Its Interaction with Adhesion Molecules in Patients with Thalassemia Intermedia

B-87 Debra A. Hoppensteadt
Activation of Prekallikrein by Contaminated Heparins, Isolated Contaminant and Related Hypersulfated Chondroitin Sulfate Preparations: Pharmacologic Implications

B-94 Jamila Hirbawi
The Function of Acidic Amino Acid Region 659-663 of Factor Va on Prothrombinase during Prothrombin Activation

B-114 Andrew N. Hoofnagle
Clinical Lipoproteomics Unveils Clusterin as a Novel Biomarker of Insulin Resistance

B-129 Stacy J. Hartman
Elevated C-Reactive Protein is Associated with Elevated LDL Particle Concentration in Patients with Normal Calculated LDL Cholesterol

Wednesday, July 22, 10:00 am

C-13 Rasha M. AlKhaldi
Adipokines and Adiponectin Gene Single Nucleotide Polymorphisms as Potential Links between Obesity and Cancer

C-28 Mathias Gehrmann
Prognosis of Distant Metastasis in Node-Negative Early Breast Cancer

C-34 John R. Petersen
A New Biomarker Panel to Predict Hepatocellular Carcinoma in Chronic HCV Patients

Wednesday, July 22, 2:00 pm

D-52 Alessandra Barassi
Fecal Calprotectin Levels in Patients with Colonic Polyposis

D-141 Matthew P. Thompson
The Correlation of Peroxiredoxin Levels and Pain in Patients with Varicella Zoster Reactivation: A Novel Biomarker for Postherpatic Neuralgia

D-148 Mario Plebani
Determination of Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) in Human Plasma: Analytical and Clinical Validation

D-151 Maria C. Gonzalez Mao
S100B Protein as a Serum Marker of Survival After Traumatic Brain Injury (TBI)

D-157 Svetlana A. Dambinova
Diagnostic Values of NMDA Receptor Peptide for Acute Ischemic Stroke

Thursday, July 23, 10:00 am

E-31 Ming Guan
Quantitative Determination of Methylation Level of DLC-1 Promoter with Methylation-Sensitive High-Resolution Melting in Prostate Cancer

E-42 Ellen Umlauf
Implication of Wild Type Glutathione S-Transferase Omega-1 as a Risk Factor in Non-APOE4 Carriers in Alzheimer's Disease

E-47 Ping Wang
Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients

E-89 Alison Woodworth
Cervicovaginal Interleukin-6 is a Predictor of Preterm Birth in African American but Not Caucasian Women

E-95 Angela M. Ferguson
The Impact of Creatinine Standardization on Dosing of Chemotherapy Drugs that are Based on Creatinine Clearance

E-141 Ron Schifman
Association of Drugs of Abuse Urine Testing with Risk of Hepatitis C Infection

E-161 Pierre Olivier Hétu
Ion Suppression Observed During Quantification of the Immunosuppressants in Blood by LC-MS/MS is Significantly Reduced by the Addition of Divalent Cations in the Extract after Protein Precipitation

Join us at this year’s annual meeting for the following Oral Presentations of Selected NACB Distinguished Abstracts, Wednesday, July 22, Afternoon Symposium, McCormick Place Convention Center, 2:30pm-5:00pm.

Moderator: Stephen Kahn, PhD, Loyola University Medical Center, Maywood, IL
Developed in cooperation with NACB

Session Overview
This session features oral presentations of the following NACB distinguished abstracts. 
Room: S402A

Clinical Lipoproteomics Unveils Clusterin as a Novel Biomarker of Insulin Resistance
Andrew N. Hoofnagle, MD, PhD
University of Washington, Seattle

Fecal Calprotectin Levels in Patients with Colonic Polyposis,
Alessandra Barassi, MD
University of Milan, Buguggiate, Vareso, Italy

The Correlation of Peroxiredoxin Levels and Pain in Patients with Varicella Zoster Reactivation: A Novel Biomarker for Postherpatic Neuralgia
Matthew P. Thompson, PhD
University of Texas Southwestern Medical Center, Mansfield TX

S100B Protein as a Serum Marker of Survival After Traumatic Brain Injury (TBI),
Maria C. Gonzalez Mao
Vigo-Pontevedra, Spain

Diagnostic Values of NMDA Receptor Peptide for Acute Ischemic Stroke,
Svetlana A. Dambinova, Dsc, PhD
Emory University, Atlanta, GA

Using Genetic and Clinical Factors to Predict Tacrolimus Dose in Renal Transplant Recipients
Ping Wang, PhD
The Methodist Hospital, Houston, TX

The Impact of Creatinine Standardization on Dosing of Chemotherapy Drugs that are Based on Creatinine Clearance
Angela M. Ferguson, PhD
Children’s Mercy Hospitals and Clinics, Kansas City, MO

 

Back to News & Views